Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases

doi: 10.1016/j.jpha.2023.05.009

• Jiuping Zeng^a,b , 
• Mingxing Li^a,b,c , 
• Qianyun Zhao^a,b , 
• Meijuan Chen^a , 
• Long Zhao^{d ,  ,}  , 
• Shulin Wei^a,b , 
• Huan Yang^a,b , 
• Yueshui Zhao^a,b,c , 
• Anqi Wang^e , 
• Jing Shen^a,b,c , 
• Fukuan Du^a,b,c , 
• Yu Chen^a,b,c , 
• Shuai Deng^a,b,c , 
• Fang Wang^a,b , 
• Zhuo Zhang^a,b , 
• Zhi Li^d , 
• Tiangang Wang^d , 
• Shengpeng Wang^f , 
• Zhangang Xiao^{a,g ,  ,}  , 
• Xu Wu^{a,f ,  ,} 

• a. Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, China;

• b. Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Luzhou, Sichuan, 646000, China;

• c. South Sichuan Institute of Translational Medicine, Luzhou, Sichuan, 646000, China;

• d. Department of Spleen and Stomach Diseases, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, China;

• e. School of Medicine, Chengdu University, Chengdu, 610106, China;

• f. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, 999078, China;

• g. Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, China